DUL.DE · ALNYLAM PHARMACE.DL-,0001
Germany · RS rating 14 · As of 2026-10-14
| Price | 202.20 EUR |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 33 / 15 / 34 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 17 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | -19.9% |
| Sales growth Q/Q | +10.6% |
| Distance from 52-week high | +50.4% |
| Market cap (USD) | $30.9B |